Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment

INTRODUCTION: Lately, the use of biological therapy in various autoimmune diseases is increasing. The ideal marker for monitoring the effects of modern therapy is still non-existent. AIM: To investigate early response biomarkers of SLE and RA patients under the rituximab treatment are in research ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecevic, Lamija, Mekic, Mevludin, Subasic, Djemo, Hadziabulic, Majda, Isak, Edmira, Subasic, Emina, Selmanovic, Kenan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007611/
https://www.ncbi.nlm.nih.gov/pubmed/32082002
http://dx.doi.org/10.5455/medarh.2019.73.374-377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007611/
https://www.ncbi.nlm.nih.gov/pubmed/32082002
http://dx.doi.org/10.5455/medarh.2019.73.374-377

Ejemplares similares